HISTOGENICS CORP - COM (HSGX)

CUSIP: 43358V109

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Equity / COM
Total 13F shares
12,306,190
Share change
+1,569,109
Total reported value
$25,208,034
Price per share
$2.05
Number of holders
24
Value change
+$3,219,817
Number of buys
14
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 43358V109?
CUSIP 43358V109 identifies HSGX - HISTOGENICS CORP - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of HISTOGENICS CORP - COM (HSGX) as of Q4 2017

As of 31 Dec 2017, HISTOGENICS CORP - COM (HSGX) was held by 24 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,306,190 shares. The largest 10 holders included Third Security, LLC, Sofinnova Management VIII, L.L.C., PERCEPTIVE ADVISORS LLC, FMR LLC, SABBY MANAGEMENT, LLC, Abingworth LLP, S Squared Technology, LLC, Vanguard Group Inc, Palo Alto Investors, LLC, and RENAISSANCE TECHNOLOGIES LLC. This page lists 24 institutional shareholders reporting positions in this security for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.